Black patients exhibited increased standardized mortality per 100,000 across all timepoints for SLE and DM with peak mortality reaching 55.6 and 4.9, respectively (Figure 1). For SSc, Asian patients had the highest mortality at 2 years only (3.2), then White patients had the highest mortality in the following years, peaking at 18.8 at 10 years. Among males, Black patients with SLE had the highest mortality across all timepoints, peaking at 11.0 at 10 years. Additionally, for males with SSc, the highest standardized mortality per 100,000 was observed in Black patients, reaching 5.8 at 10 years. For DM, Asian patients exhibited increased mortality from 3-5 years (2.8), with White patients exhibiting the highest 10-year mortality (2.9).These findings from a large, national database demonstrate the racial and gender-based differences in prevalence and mortality for three CTDs: SLE, SSc, and DM. Our study shows that Black males had highest mortality in SSc and SLE, and Black females in DM and SLE compared to White counterparts. While mortality curves frequently cross at earlier timepoints, differences observed at the 10-year timepoint and overall increasing trends in standardized mortality suggest the need for additional research to determine underlying causes of mortality disparities and develop targeted interventions to reduce the mortality burden.